Reference SummaryCarmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5
Title |
The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue | ||||||
Authors |
Carmichael NG; Debruyne EL; Bigot-Lasserre D | ||||||
Journal |
Environ Health Perspect | ||||||
Volume |
108 | ||||||
Issue |
1 | ||||||
Year |
2000 | ||||||
Pages |
61-5 | ||||||
Abstract |
Heterozygous p53 knockout mice were investigated as a potential model for vascular tumor carcinogenesis. Groups of 20 male mice were exposed by gavage for 6 months to the vascular carcinogen urethane at 1, 10, or 100 mg/kg body weight/day. Wild-type and heterozygous p53 knockout control groups were exposed by gavage to the vehicle alone. Another group of 20 male mice received d-limonene by gavage (d-limonene is noncarcinogenic in mice). The high dose of urethane caused early mortality in the majority of mice associated with histopathologic evidence of toxicity and tumors, including a high incidence of benign and malignant vascular tumors, in all animals. At the intermediate dose, toxicity was less marked and 3 of 20 mice had tumors; mice that received the low dose did not have signs of toxicity or neoplasia. The two control groups had no tumors and the d-limonene group had one tumor of the prostate, which was considered spontaneous. We conclude that the p53 knockout mouse is a useful tool for investigating vascular tumorogenesis. | ||||||
Links |
J:60035 – MGI References 10620525 – National Library of Medicine/PubMed |
||||||
Strain Notes
|
|||||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| B6.129S7 | Blood vessel hemangioma | Liver |
0 |
||
| B6.129S7 | Blood vessel hemangioma | Heart |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma | Liver |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma | Heart |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma |
|
Liver |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma |
|
Heart |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma |
|
Liver |
0 - 65 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangioma |
|
Heart |
0 - 5 |
|
| B6.129S7 | Blood vessel hemangiosarcoma | Spleen |
0 |
||
| B6.129S7 | Blood vessel hemangiosarcoma | Liver |
0 |
||
| B6.129S7 | Blood vessel hemangiosarcoma | Abdominal cavity |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma | Spleen |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma | Liver |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma | Abdominal cavity |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Liver |
0 - 40 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Spleen |
0 - 5 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Abdominal cavity |
0 - 5 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Abdominal cavity |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Spleen |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hemangiosarcoma |
|
Liver |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hyperplasia |
|
Liver |
10 |
|
| B6.129S7-Trp53tm1Brd/+ | Blood vessel hyperplasia |
|
Heart |
5 |
|
| B6.129S7-Trp53tm1Brd/+ | Forestomach hyperplasia |
|
Forestomach |
85 |
|
| B6.129S7 | Leukocyte lymphoma | Thymus |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Leukocyte lymphoma | Thymus |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Leukocyte lymphoma |
|
Thymus |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Leukocyte lymphoma |
|
Thymus |
0 - 15 |
|
| B6.129S7-Trp53tm1Brd/+ | Liver hepatocellular carcinoma | Liver |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Liver hepatocellular carcinoma |
|
Liver |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Liver hepatocellular carcinoma |
|
Liver |
0 - 20 |
|
| B6.129S7 | Liver hepatocellular carcinoma | Liver |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Liver hyperplasia - oval cell |
|
Liver |
0 - 10 |
|
| B6.129S7-Trp53tm1Brd/+ | Liver hyperplasia - oval cell |
|
Liver |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Liver hyperplasia - oval cell | Liver |
0 |
||
| B6.129S7 | Liver hyperplasia - oval cell | Liver |
0 |
||
| B6.129S7 | Lung adenoma | Lung |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Lung adenoma | Lung |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Lung adenoma |
|
Lung |
0 - 25 |
|
| B6.129S7-Trp53tm1Brd/+ | Lung adenoma |
|
Lung |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Mesodermal cell/mesoblast sarcoma | Subcutis |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Mesodermal cell/mesoblast sarcoma |
|
Subcutis |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Mesodermal cell/mesoblast sarcoma |
|
Subcutis |
0 - 5 |
|
| B6.129S7 | Mesodermal cell/mesoblast sarcoma | Subcutis |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Prostate gland adenoma | Prostate gland |
0 |
||
| B6.129S7 | Prostate gland adenoma | Prostate gland |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | Prostate gland adenoma |
|
Prostate gland |
0 |
|
| B6.129S7-Trp53tm1Brd/+ | Prostate gland adenoma |
|
Prostate gland |
5 |
|
| B6.129S7-Trp53tm1Brd/+ | Prostate gland hyperplasia - focal | Prostate gland |
20 |
||
| B6.129S7 | Prostate gland hyperplasia - focal | Prostate gland |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
| B6.129S7 | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
| B6.129S7-Trp53tm1Brd/+ | (Unspecified organ) tumor |
|
(Unspecified organ) |
0 - 100 |
|
| B6.129S7-Trp53tm1Brd/+ | (Unspecified organ) tumor |
|
(Unspecified organ) |
5 |